Who Owns the Step Therapy Exception?
By Erik Beshlikyan · Adapted from graduate coursework in Healthcare Administration and Policy at Arizona State University
Why specialty patients stall between denial and approval, and the three operational fixes that close the gap
Most step therapy exceptions don't stall because someone said no. They stall because, between the claim rejection and the final answer, nobody owns them.
Picture a familiar case. A specialist prescribes a biologic. The pharmacy claim rejects because the plan wants the patient to try a preferred drug first. The pharmacy tells the office, and the office files an exception request. The plan asks for more chart notes, and the request goes back to the office. Everyone did their part. Meanwhile the patient has waited weeks, called three phone numbers, and still can't find out where the request stands.
That gap is an operations problem, and operations tools can close it: one named owner, a tracker that won't let a request go quiet, and a written agreement with the partners who share the process.
How an exception moves today
A step therapy exception usually passes through five steps and three or four organizations. Each one owns its own step. No one owns the path from start to finish.
Step | Who owns it |
1. Prescription written | Prescriber |
2. Claim rejects for step therapy | Pharmacy |
3. Exception request submitted | Prescriber's office |
4. Plan review (may loop back to step 3 when more information is requested) | PBM or plan |
5. Patient outcome communicated | No one assigned |
Every move from one step to the next is a handoff, and every handoff is a place where a request can sit unnoticed. Watch the loop most closely. When the plan asks for more information, the request has to find its way back to someone who can answer it, and the clock is already running.
The real problem: nobody owns the exception
When we map this process and trace the delays back to their cause, the same answer keeps coming up. It isn't the forms, the portals or any single slow reviewer. It's fragmented accountability: no single person or organization owns the exception from the moment the claim rejects to a final, documented outcome for the patient.
Each party owns one step. The office owns the paperwork, the pharmacy owns the claim, the PBM or plan owns the decision. The handoffs between those steps belong to no one. That is where requests sit unanswered, where a request for more information goes unseen, and where patients give up.
The cost is well documented. In the American Medical Association's 2025 prior authorization survey, 95% of physicians reported care delays, and 75% reported ineffective initial treatment, with step therapy named as a cause. Physicians and their staff reported spending 13 hours each week completing prior authorizations.
Adding rules doesn't fix a handoff problem. Arizona law already gives state-regulated insurers and PBMs 72 hours to decide a standard step therapy exception request and 24 hours when the situation is urgent. If the prescriber gets neither a decision nor a request for more information in that window, the exception is deemed granted. That protection only works if someone on the provider side is watching the clock.
Fix 1: Name one exception owner
Give every step therapy exception one owner, from the moment the claim rejects until the patient has a final, documented outcome. That person is the single point of contact for the patient, the prescriber and the plan, and the one who knows where the request stands on any given day.
In a specialty practice, this role usually fits within the medication access or prior authorization team. It doesn't need to be a new hire. It needs a clear definition:
Starts at: the rejected claim or the pharmacy's notice, not the moment someone gets around to the paperwork
Ends at: a documented outcome the patient has been told about, whether approval, denial with appeal filed, or a switch to an alternative therapy
Owns: gathering documentation, submitting the request, answering plan requests for more information, and updating the patient
Escalates: when a statutory or contractual deadline is close to passing without a response
The point isn't more work. It's moving the work that already happens out of the gaps and into one person's queue.
Fix 2: Track it so a request can't go quiet
An owner needs something to be held to. The second fix is a shared exception tracker with one rule: a request can't be closed or moved to the next stage without an assigned owner and a current status.
That rule is a forcing function. It makes the failure, an exception sitting with nobody, impossible rather than just discouraged. Telling staff to be more careful works for a week. A required field works every time.
The tracker can live in your EHR worklist, your CRM or a well-built shared sheet. What matters is the fields:
Field | Why it matters |
Owner | The one person accountable today |
Stage | Rejected, documenting, submitted, more info requested, decided, patient notified |
Date submitted | Starts the plan's response clock |
Response deadline | 72 or 24 hours under Arizona law, or your plan contract's terms |
Next action and due date | Keeps the request moving between touches |
Last patient update | Closes the loop with the person waiting |
One caution: an owner field in software is not the same as an owner. The tracker makes accountability visible. The role in Fix 1 is what makes it real.
Fix 3: Put the handoffs in writing with your partners
The first two fixes work inside your walls. Most delays happen at the handoffs between organizations, and that is where incentives work against the patient. Under fee-for-service payment, no single organization pays for an unresolved exception. The delay and the rework land on the patient instead.
A short written agreement with the partners you work with most, usually your specialty pharmacies and, where they're willing, the plans' provider relations teams, gives the handoffs an owner too. It should name:
A contact on each side for exception questions
How the pharmacy notifies your office of a step therapy rejection, and how fast
How requests for more information reach your exception owner, not a general inbox
An escalation path when a deadline is about to pass
Without this layer, the first two fixes stop at your front door. With it, everyone touching the request knows who to call.
What the federal rules change, and what they don't yet
Federal policy is moving toward faster, electronic prior authorization, but drugs have lagged behind. Here is where things stand as of November 2026:
CMS-0057-F (final). Decision timeframes have been in effect since January 1, 2026, and the electronic Prior Authorization API is required beginning January 1, 2027. It covers Medicare Advantage, Medicaid and CHIP, and federal exchange plans, with decisions in 72 hours for urgent requests and 7 calendar days for standard ones. For step therapy: drug prior authorizations are excluded, so it doesn't reach step therapy exceptions for medications.
CMS-0062-P (proposed). Proposed April 10, 2026; the comment period closed June 15, 2026. It would extend electronic prior authorization, shorter decision timeframes and public reporting to drugs for the same plan types. For step therapy: it would reach drug exceptions directly, but isn't final. Some data standards it proposed were adopted separately, effective October 1, 2026.
Two things follow. The January 2027 API deadline won't solve step therapy delays for medications. And commercial plans fall outside both rules, so practices will keep relying on state law and their own processes. The owner, the tracker and the agreements work under any rule. Practices that build them now will be ready when the drug rule is finalized, instead of scrambling to catch up.
What to measure
Four numbers tell you whether the fixes are working. Measure a baseline for one month before changing anything, then track monthly.
Measure | What it tells you |
Median days from claim rejection to final outcome | Whether patients are getting answers faster |
Percent of requests returned for more information | Whether handoff and documentation gaps are closing |
Percent of requests with an owner and a patient update within two business days | Whether the owner role is actually being used |
Percent of requests with an owner assigned at intake | Whether the tracker is adopted. It should be close to 100% by design; lower means people are working around it |
Set targets against your own baseline, not someone else's benchmark. A practice that cuts its median time in half has solved a real problem, whatever the starting number.
Where to start this month
Pull your last 20 step therapy exceptions and write down, for each, who held it at every stage. The gaps will show up quickly.
Name one exception owner and write down where the role starts and ends.
Add an owner field and a stage field to whatever system you track requests in, and make both required.
Call your highest-volume specialty pharmacy and agree on how step therapy rejections will reach your owner.
Record your baseline numbers before anything else changes.
Step therapy exceptions don't stall because people aren't working hard. They stall because the process was never designed to have an owner. That's a design problem, and design problems can be fixed.
EMB Integrated Health Solutions helps specialty practices map their medication access workflows, find where requests stall, and set up the ownership, tracking and measures to fix them. Schedule an operations assessment.
Sources
American Medical Association. 2025 AMA Prior Authorization Physician Survey.
Arizona Legislature. A.R.S. § 20-3654, Exceptions; process.
Centers for Medicare & Medicaid Services. CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) fact sheet.
Centers for Medicare & Medicaid Services. 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P) fact sheet. April 10, 2026.
Federal Register. Interoperability Standards and Prior Authorization for Drugs proposed rule. April 14, 2026.



